Half-year report · HY
3154.TEDINET S100XKN4
Period2025-07-01 → 2025-12-31
Filed2026-02-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥149.2bn | 2025-07-01 → 2025-12-31 | Cons. | Net sales |
| Revenue | ¥288.7bn | 2024-07-01 → 2025-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥142.7bn | 2024-07-01 → 2024-12-31 | Cons. | Net sales |
| Operating income | ¥585m | 2025-07-01 → 2025-12-31 | Cons. | Operating income |
| Operating income | ¥751m | 2024-07-01 → 2024-12-31 | Cons. | Operating income |
| Ordinary income | ¥817m | 2025-07-01 → 2025-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.4bn | 2024-07-01 → 2025-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥983m | 2024-07-01 → 2024-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥803m | 2025-07-01 → 2025-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥983m | 2024-07-01 → 2024-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥387m | 2025-07-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.4bn | 2024-07-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥407m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥388m | 2025-07-01 → 2025-12-31 | Cons. | Profit loss |
| Net income | ¥407m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss |
| Total assets | ¥127.6bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥113.0bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥119.8bn | at 2024-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥107.4bn | at 2025-12-31 | Cons. | Liabilities |
| Total liabilities | ¥92.5bn | at 2025-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥20.3bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥20.5bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥20.0bn | at 2024-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥19.2bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥14.3bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥19.2bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.3bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.0bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.5bn | at 2024-06-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥1.6bn | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥7.0bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.5bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥605m | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.5bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.4bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥7.1bn | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.5bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥586m | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥17.41 | 2025-07-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥61.91 | 2024-07-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.32 | 2024-07-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥17.39 | 2025-07-01 → 2025-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥61.85 | 2024-07-01 → 2025-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥18.32 | 2024-07-01 → 2024-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 15.9% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 18.1% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 16.7% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-07-01 → 2025-12-31 | −¥9m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-07-01 → 2025-12-31 | −¥9m |
| Reconciling Itemsreconciling | segment profit | 2025-07-01 → 2025-12-31 | −¥4.2bn |
| Medical Equipment Salesreportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥146.1bn |
| Medical Equipment Salesreportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥146.1bn |
| Medical Equipment Salesreportable segment | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥9m |
| Medical Equipment Salesreportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥4.5bn |
| Nursing Care And Welfarereportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥3.1bn |
| Nursing Care And Welfarereportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥3.1bn |
| Nursing Care And Welfarereportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥308m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-07-01 → 2025-12-31 | ¥149.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-07-01 → 2025-12-31 | ¥149.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥9m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-07-01 → 2025-12-31 | ¥4.8bn |
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2024-12-31 | −¥9m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2024-12-31 | −¥9m |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2024-12-31 | −¥4.5bn |
| Medical Equipment Salesreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥139.7bn |
| Medical Equipment Salesreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥139.7bn |
| Medical Equipment Salesreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥9m |
| Medical Equipment Salesreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥5.0bn |
| Nursing Care And Welfarereportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥3.0bn |
| Nursing Care And Welfarereportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥3.0bn |
| Nursing Care And Welfarereportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥250m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-07-01 → 2024-12-31 | ¥142.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-07-01 → 2024-12-31 | ¥142.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥9m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-07-01 → 2024-12-31 | ¥5.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 563
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | InterimInstant_No2MajorShareholdersMember | 2188722 | |
| Shareholding ratio | InterimInstant_No2MajorShareholdersMember | 0.098 | |
| Number of shares held | InterimInstant_No3MajorShareholdersMember | 1920000 | |
| Shareholding ratio | InterimInstant_No3MajorShareholdersMember | 0.086 | |
| Number of shares held | InterimInstant_No4MajorShareholdersMember | 1093804 | |
| Shareholding ratio | InterimInstant_No4MajorShareholdersMember | 0.049 | |
| Number of shares held | InterimInstant_No5MajorShareholdersMember | 1072700 | |
| Shareholding ratio | InterimInstant_No5MajorShareholdersMember | 0.048 | |
| Number of shares held | InterimInstant_No6MajorShareholdersMember | 681699 | |
| Shareholding ratio | InterimInstant_No6MajorShareholdersMember | 0.031 | |
| Number of shares held | InterimInstant_No7MajorShareholdersMember | 578500 | |
| Shareholding ratio | InterimInstant_No7MajorShareholdersMember | 0.026 | |
| Number of shares held | InterimInstant_No8MajorShareholdersMember | 482084 | |
| Shareholding ratio | InterimInstant_No8MajorShareholdersMember | 0.022 | |
| Number of shares held | InterimInstant_No9MajorShareholdersMember | 396900 | |
| Shareholding ratio | InterimInstant_No9MajorShareholdersMember | 0.018 | |
| Number of shares held | InterimInstant_No10MajorShareholdersMember | 382800 | |
| Shareholding ratio | InterimInstant_No10MajorShareholdersMember | 0.017 | |
| Number of shares held | InterimInstant | 10987209 | |
| Shareholding ratio | InterimInstant | 0.494 | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 900 | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 22226300 | |
| Number of voting rights issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 222263 | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesSharesLessThanOneUnitMember | 11017 | |
| Number of shares issued shares voting rights | InterimInstant | 22238217 | |
| Number of voting rights issued shares voting rights | InterimInstant | 222263 | |
| Number of shares held in own name treasury shares etc | InterimInstant_Row1Member | 900 | |
| Number of shares held in others names treasury shares etc | InterimInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | InterimInstant_Row1Member | 900 | |
| Shareholding ratio treasury shares etc | InterimInstant_Row1Member | 0.000 | |
| Number of shares held in own name treasury shares etc | InterimInstant | 900 | |
| Number of shares held in others names treasury shares etc | InterimInstant | － | |
| Total number of shares held treasury shares etc | InterimInstant | 900 | |
| Shareholding ratio treasury shares etc | InterimInstant | 0.000 | |
| Cash and deposits | Prior1YearInstant | 14333767000 | JPY |
| Cash and deposits | InterimInstant | 19249684000 | JPY |
| Notes and accounts receivable trade | Prior1YearInstant | 57988850000 | JPY |
| Notes and accounts receivable trade | InterimInstant | 66158527000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 13600867000 | JPY |
| Merchandise and finished goods | InterimInstant | 14987636000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 10963000 | JPY |
| Raw materials and supplies | InterimInstant | 9825000 | JPY |
| Other ca | Prior1YearInstant | 3261676000 | JPY |
| Other ca | InterimInstant | 4109502000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -143247000 | JPY |
| Allowance for doubtful accounts ca | InterimInstant | -148121000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |